Sam Brusco, Associate Editor01.19.24
Cynosure and Lutronic have entered into a definitive merger agreement. Both companies are providers of energy-based medical aesthetic treatment systems and related technologies.
The strategic combination creates a diversified product portfolio with commercial presence in over 130 countries. Customers and patients will have access to a broader suite of products and consumables, related clinical training and services, and expanded R&D capabilities.
Cynosure provides medical aesthetic treatment systems for dermatologists, medical spas, and other healthcare practitioners for both non-invasive and minimally invasive procedures. The company’s portfolio spans skin revitalization, body contouring, and hair removal.
Lutronic adds intelligent laser and energy-based systems to Cynosure’s portfolio. The company has products for skin resurfacing and revitalization, hair removal, vascular lesion treatment, skin toning, and body contouring. These procedures utilize laser, radiofrequency, and electric muscle stimulation technologies.
"The strategic combination will create a combined company with the resources, product portfolio and expertise that will benefit our customers, partners and employees," said Nadav Tomer, CEO of Cynosure. "We are thrilled that Cynosure is partnering with Lutronic as we believe this will create a distinct opportunity to combine two strong global players in energy-based medical device technology for aesthetics."
"Partnering with Cynosure is a meaningful and transformational next step in diversifying our portfolio and scaling our company," added Haelyung Hwang, founder and CEO of Lutronic. "This strategic combination furthers Lutronic's mission to drive innovation and provide superior products and customer service to aesthetics providers around the world. Cynosure's innovative medical device technology, commercial infrastructure and best-in-class brand-building capabilities will broaden our product line and customer base globally."
The transaction is expected to close in Q1 2024, and the transaction’s terms were not disclosed.
The strategic combination creates a diversified product portfolio with commercial presence in over 130 countries. Customers and patients will have access to a broader suite of products and consumables, related clinical training and services, and expanded R&D capabilities.
Cynosure provides medical aesthetic treatment systems for dermatologists, medical spas, and other healthcare practitioners for both non-invasive and minimally invasive procedures. The company’s portfolio spans skin revitalization, body contouring, and hair removal.
Lutronic adds intelligent laser and energy-based systems to Cynosure’s portfolio. The company has products for skin resurfacing and revitalization, hair removal, vascular lesion treatment, skin toning, and body contouring. These procedures utilize laser, radiofrequency, and electric muscle stimulation technologies.
"The strategic combination will create a combined company with the resources, product portfolio and expertise that will benefit our customers, partners and employees," said Nadav Tomer, CEO of Cynosure. "We are thrilled that Cynosure is partnering with Lutronic as we believe this will create a distinct opportunity to combine two strong global players in energy-based medical device technology for aesthetics."
"Partnering with Cynosure is a meaningful and transformational next step in diversifying our portfolio and scaling our company," added Haelyung Hwang, founder and CEO of Lutronic. "This strategic combination furthers Lutronic's mission to drive innovation and provide superior products and customer service to aesthetics providers around the world. Cynosure's innovative medical device technology, commercial infrastructure and best-in-class brand-building capabilities will broaden our product line and customer base globally."
The transaction is expected to close in Q1 2024, and the transaction’s terms were not disclosed.